Tony Kin Wai Hung

Tony Kin Wai Hung

Auto-generated profile, based on publicly available information

Tony Kin Wai Hung

Cancer Institute, Hartford HealthCare , Hartford, CT 06106

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2021 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
Mingxiao YangMingxiao Yang
Mingxiao Yang
KLKevin T T. Liou
Kevin T T. Liou
SGSheila N. Garland
Sheila N. Garland
TBTing Bao
Ting Bao
THTony K. W. Hung
Tony K. W. Hung
JMJun J Mao
Jun J Mao
Pain and insomnia often co-occur and impair the quality of life in cancer survivors. This study evaluated the effect of acupuncture versus cognitive behavioral therapy for insomnia (CBT-I) on pain severity among cancer survivors with comorbid pain and insomnia. Using data from the CHOICE trial that compared acupuncture versus CBT-I for insomnia among cancer survivors, we analyzed the effect of interventions on pain outcomes in 70 patients with moderate to severe baseline pain. Interventions were delivered over eight weeks. We assessed average pain severity (primary outcome) and pain interference at baseline, week 8, and week 20. We further defined insomnia and pain responders as patients who achieved clinically meaningful improvement in insomnia and pain outcomes, respectively, at week 8. We found that compared with baseline, the between-group difference (-1.0, 95% CI -1.8 to -0.2) was statistically significant favoring acupuncture for reduced pain severity at week 8 (-1.4, 95% CI -2.0 to -0.8) relative to CBT-I (-0.4, 95% CI-1.0 to 0.2). Responder analysis showed that 1) with acupuncture, insomnia responders reported significantly greater pain reduction from baseline to week 4, compared with insomnia non-responders (-1.5, 95% CI -2.7 to -0.3); 2) with CBT-I, pain responders reported significantly greater insomnia reduction at week 8, compared with pain non-responders (-4.7, 95% CI -8.7 to -1.0). These findings suggest that among cancer survivors with comorbid pain and insomnia, acupuncture led to rapid pain reductions, which contributed to a decrease in insomnia, whereas CBT-I had a delayed effect on pain, possibly achieved by insomnia improvement.

24 April 2019 in Pain Medicine
Verified
Journal Article
Open access
KLKevin T T. Liou
Kevin T T. Liou
THTony K W Hung
Tony K W Hung
SMSalimah H Meghani
Salimah H Meghani
AEAndrew S Epstein
Andrew S Epstein
QLQ Susan Li
Q Susan Li
JMJun J Mao
Jun J Mao
Objective: In response to the national opioid crisis, governmental and medical organizations have called for broader insurance coverage of acupuncture to improve access to nonpharmacologic pain therapies, especially in cancer populations, where undertreatment of pain is prevalent. We evaluated whether cancer patients would be willing to use insurance-covered acupuncture for pain. Design and Setting: We conducted a cross-sectional survey of cancer patients with pain at one academic center and 11 community hospitals. Methods: We used logistic regression models to examine factors associated with willingness to use insurance-covered acupuncture for pain. Results: Among 634 cancer patients, 304 (47.9%) reported willingness to use insurance-covered acupuncture for pain. In univariate analyses, patients were more likely to report willingness if they had severe pain (odds ratio [OR] = 1.59, 95% confidence interval [CI] = 1.03–2.45) but were less likely if they were nonwhite (OR = 0.59, 95% CI = 0.39–0.90) or had only received high school education or less (OR = 0.46, 95% CI = 0.32–0.65). After adjusting for attitudes and beliefs in multivariable analyses, willingness was no longer significantly associated with education (adjusted OR [aOR] = 0.78, 95% CI = 0.50–1.21) and was more negatively associated with nonwhite race (aOR = 0.49, 95% CI = 0.29–0.84). Conclusions: Approximately one in two cancer patients was willing to use insurance-covered acupuncture for pain. Willingness was influenced by patients’ attitudes and beliefs, which are potentially modifiable through counseling and education. Further research on racial disparities is needed to close the gap in utilization as acupuncture is integrated into insurance plans in response to the opioid crisis.

15 October 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
THTony K W Hung
Tony K W Hung
GKGilad J Kuperman
Gilad J Kuperman
ESEric J Sherman
Eric J Sherman
AHAlan L Ho
Alan L Ho
CWChunhua Weng
Chunhua Weng
JMJun J Mao
Jun J Mao
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). In this study, we evaluated the performance of a retrieval-augmented language model, powered by GPT-4, to recommend appropriate clinical trial recommendations for a head & neck cancer population at the Memorial Sloan Kettering Cancer Center. We demonstrated that retrieval-augmented LLM could achieve moderate performance, exceeding the historical performance of untrained LLMs to provide oncology treatment recommendations by 4-20 folds. Our study provided insights into the rarely measured performance of retrieval-augmented LLM using real-world patient cases in comparison to physician expert recommendations.

1 February 2025 in JCO Clinical Cancer Informatics
Verified
Journal Article
Closed access
ESEthan Shin
Ethan Shin
JCJustin Choi
Justin Choi
THTony K.W. Hung
Tony K.W. Hung
CPChester Poon
Chester Poon
NRNadeem Riaz
Nadeem Riaz
JKJung Julie Kang
Jung Julie Kang
PURPOSE: Treatment deintensification for human papillomavirus–positive (HPV+)-associated oropharyngeal cancer (OPC) has been the catalyst of experts worldwide. In situ hybridization is optimal to identify HPV+ OPC, but immunohistochemistry for its surrogate p16INK4a (p16) is standard-of-care given its availability and sensitivity. HPV testing is not required for clinical management, so treatments are often administered on the basis of p16 status alone. However, the prognosis of p16/HPV discordant tumors is uncertain. MATERIALS AND METHODS: This cohort study included 727 consecutive patients with OPC with digitized unstructured pathology reports receiving curative radiation therapy at an academic cancer center. Natural language processing (NLP) methods were used to classify biomarker status and compared against manually derived classification. Patients were excluded if either p16 or HPV testing was not performed or equivocal. Primary end points were progression-free survival (PFS), cancer-specific survival (CSS), and overall survival. RESULTS: NLP classified p16 and HPV status from a majority (91%) of reports. Accuracy, positive predictive value, sensitivity, and F -score for NLP-derived p16/HPV were 84%/82%, 91%/87%, 90%/89%, and 90%/88%, respectively. Four groups were identified: p16-positive (p16+)/HPV+ (75%), p16+/HPV-negative (HPV–; 13%), p16-negative (p16–)/HPV– (10%), and p16–/HPV+ (2%). There was no statistically significant difference in outcomes between p16+/HPV– and p16–/HPV– patients (5-year PFS 76.1% v 68.9%; P = .12; 5-year CSS 81.5% v 84.9%; P = .22). Number needed to harm calculations estimated one excess cancer-related death for every 10 p16+/HPV– patients, compared with that expected with p16+/HPV+ patients. CONCLUSION: NLP classified head and neck cancer pathology reports with high concordance with gold-standard categorization, but a conspicuous portion of reports could not be interpreted. p16/HPV discordant OPC constitutes a noteworthy minority of patients. The inferior prognosis of p16+/HPV– suggests that p16 alone for prognostication is insufficient—especially when considering treatment de-escalation.

28 July 2025 in Journal of the American Medical Informatics Association
Verified
Journal Article
Closed access
THTony K W Hung
Tony K W Hung
JMJun J Mao
Jun J Mao
AHAlan L Ho
Alan L Ho
ESEric J Sherman
Eric J Sherman
MRMark Robson
Mark Robson
DPDavid G Pfister
David G Pfister
Objectives: This quality improvement study implemented and prospectively examined user engagement with an artificial intelligence (AI)-powered clinical trial knowledge management application at an NCI-designated comprehensive cancer center. Materials and Methods: We prospectively auto-captured user engagement measures from July 1, 2022 to February 29, 2024. Measurement included: (1) event: an app interaction; (2) session: group of events within single setting; (3) engaged session: session longer than 10 s; (4) engagement time; (5) app downloads; (6) active user; and (7) stickiness: monthly active users per normalized total downloads. We analyzed the measures using time series and linear regression. Results: During a 20-month evaluation, the application supported 138 clinical trials, recorded 136 632 user interactions, including 2754 engaged sessions with an average engagement time of 6 min 31 s. Of 243 downloads, 228 (94%) users remained active, with an estimated stickiness score of 3.12 (SD 0.91), indicating sustained provider engagement. Discussion: This study provided insights into the feasibility and potential for integrating an AI-powered clinical trial knowledge management application into oncology workflows, with sustained engagement among providers over a 20-month period. High rates of active users and session stickiness suggest that such application offered meaningful utility in real-world clinical settings, underscoring the need for future studies to assess optimal integration strategies and impact on clinical trial accrual. Conclusion: This study addresses an important gap in the literature regarding the real-world integration of AI technologies in oncology care and offers valuable insights for future research and clinical practice.

18 November 2022 in JCO Oncology Practice
Verified
Journal Article
Closed access
THTony K.W. Hung
Tony K.W. Hung
SLShelly Latte-Naor
Shelly Latte-Naor
YLYuelin Li
Yuelin Li
GKGilad J. Kuperman
Gilad J. Kuperman
CSChristina Seluzicki
Christina Seluzicki
JMJun J Mao
Jun J Mao
PURPOSE:Accelerated by the COVID-19 pandemic, the virtual platform has become a prominent medium to deliver mind-body therapies, but the extent to which patients engage in virtual mind-body programming remains unclear. This study aims to assess oncology patient engagement in a virtual mind-body program.METHODS:We surveyed oncology patients enrolled in a live-streamed (synchronous) virtual mind-body program in May 2021. Patients self-reported engagement by weekly attendance. We applied multivariate regression to identify associations of engagement with sociodemographic and clinical factors. As an exploratory analysis, we used machine learning to partition engagement subgroups to determine preferential interest in prerecorded (asynchronous) mind-body therapy videos.RESULTS:Among 148 patients surveyed (response rate: 21.4%), majority were female (94.5%), White (83.1%), age 65 years or older (64.9%), retired (64.2%), and in survivorship (61.8%). Patient engagement ranged from 1 to 13 classes/week (mean [standard deviation]: 4.23 [2.56]) and was higher for female (beta, .82; 95% CI, 0.01 to 1.62), non-White (beta, .63; 95% CI, 0.13 to 1.13), and retired patients (beta, .50; 95% CI, 0.12 to 0.88). The partition model identified three engagement subgroups: employed (low engagers), retired White (intermediate engagers), and retired non-White (high engagers). Particularly, low engagers had preferential interest in meditation videos (odds ratio, 2.85; 95% CI, 1.24 to 6.54), and both low and high engagers had preferential interest in Tai Chi videos (odds ratio, 2.26; 95% CI, 1.06 to 4.82).CONCLUSION:In this cross-sectional study among oncology patients, engagement in virtual mind-body programming was higher for female, non-White, and retired patients. Our findings suggest the need for both synchronous and asynchronous mind-body programming to meet the diverse needs of oncology patients.